NPPA Revises ceiling prices of 21 formulations under Drugs (Price control) Order 2013
The National Pharmaceutical Pricing Authority has revised ceiling prices for 21 formulations under para 19 of Drugs (Price control) order 2013. These drugs are used as first line of treatment and are crucial to the public health program of the country
The High Court of Judicature at Patna (HC) orders the closure of all illegal laboratories, Diagnostic centers, Clinics & Nursing homes in the State
The High Court of Judicature at Patna (HC) has passed Judgement on 09-12-2019, ordering the closure of all pathological laboratories, Diagnostic centers, Clinics and Nursing homes which has developed illegally in the State of Bihar. While passing Judgement on the writ petition filed by Indian Association Of Pathologists And Microbiologists, with the State Of Bihar […]
CDSCO directs all drug manufactures to upload every information about their licenses and approved products on SUGAM portal
New CDSCO guidelines directs every firm to do self-registration with valid email by submitting registration form. Once registered, they shall proceed with the process of uploading of data regarding license and products.
Healthcare professionals and clinicians to report every medical devices adverse event they encounter to MVPI-Indian Pharmacopoiea commission
The Central Drugs standard control organisation vide Notification dated 26th November 2019 has directed every state drug controller to advice every clinicians and other healthcare professional to mandatorily report about medical devices adverse event to Materiovigilance Programme of India (“MvpPI”).
CDSCO Issues notification on processing of application for product approved as medical device
The Central Drugs Standard Control Organization in its Notification dated 15th November 2019 has issued an Office Memorandum directing that the processing of application for product approved as medical device in the country of origin and not covered under the medical devices notified in India shall be done by New Drugs division or Import division of CDSCO .
Haryana government mandates hospitals to notify the health department about the cases of Influenza A H1N1
The State Government of Haryana in its Notification dated 19th November 2019 has published the Haryana Epidemic Diseases, Influenza A H1N1 Regulation, 2019, under which all hospitals are obligated to report to health department about, and provide treatment as per guidelines to, all suspected and confirmed cases of the epidemic infection.
Digital thermometer, BP monitoring devices to come under regulation from January 1, 2020
The Central Drugs Standard Control Organisation In its notification dated 13th November 2019, has brought in devices that are used to monitor temperature or blood pressure under new medical device Rules, 2019 effective from 1st January 2020.
The Central Drugs Standard Control Organization soon to exempt sale license on import of high tech equipment’s
The Drugs Controller General of India (DCGI) is planning to recommend Drug Technical Advisory Board (DTAB) to exempt drug sale license for import of high tech equipment like X-Ray, MRI, PET, Ultrasound and CT Scan based on stakeholders suggestions.
Drugs and cosmetics (Thirteenth Amendment) Rules, 2019 directs manufacturers to furnish undertaking for not marketing drugs having similar brand names
The Ministry of health and family welfare, has published the Drugs and Cosmetics effective from 6th November 2019, with the object of preventing drugs of deceptively similar brand names being available in the market.
Change in Drug Supplying entities: New Draft Drugs and Cosmetic Amendment Rules
The Ministry of Health and Family Welfare in its notification dated 6th November, 2019 has published the Draft Drugs and Cosmetics (Amendment) Rules, 2019 by amending the classes of drugs supplied by entities and their extent and conditions of exemption.
